<DOC>
	<DOCNO>NCT00716963</DOCNO>
	<brief_summary>The investigator propose 3-treatment , placebo-controlled , double-dummy , double-blinded , randomize , crossover study single dos placebo , compare Fluticasone propionate ( Flovent Diskus ) 250 mcg budesonide 400 mcg administer allergen challenge , cessation early allergic reaction ( 20 % fall FEV1 post-allergen peak )</brief_summary>
	<brief_title>Does Fluticasone Propionate Reduce Late Allergic Reaction When Drug Given Post-allergen ?</brief_title>
	<detailed_description>The aim pilot study evaluate whether fluticasone propionate affect late allergic reaction single dose post-allergen challenge administer follow cessation early allergic reaction . Six subject mild asthma ask volunteer study.The diagnosis asthma include presence variable airflow limitation AHR ( PC20 methacholine &lt; 16 mg/mL ) . Subjects ask participate demonstrate allergen-induced early late asthmatic response least 20 % 15 % reduction FEV1 , respectively . The study consist 4 period , compose screen allergen period 3 subsequent allergen challenge/treatment period . Each period separate washout least 2 week . Subjects demonstrate dual asthmatic response screen period select randomization treatment .</detailed_description>
	<mesh_term>Hypersensitivity</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<criteria>mild asthma nonsmoker allergeninduced early late asthmatic response medication infrequent ( &lt; twice weekly ) inhale beta2agonists expose sensitize allergen asthma exacerbation respiratory tract infection past4 week</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>late allergic response</keyword>
	<keyword>fluticasone propionate</keyword>
</DOC>